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Cell electrofusion is a phenomenon that occurs, when cells are in close contact and exposed to short high-
voltage electric pulses. The consequence of exposure to pulses is transient and nonselective permeabilization
of cell membranes. Cell electrofusion and permeabilization depend on the values of electric ﬁeld parameters
including amplitude, duration and number of electric pulses and direction of the electric ﬁeld. In our study,
we ﬁrst investigated the inﬂuence of the direction of the electric ﬁeld on cell fusion in two cell lines. In both
cell lines, applications of pulses in two directions perpendicular to each other were the most successful. Cell
electrofusion was ﬁnally used for production of human–mouse heterohybridoma cells with modiﬁed Koehler
and Milstein hybridoma technology, which was not done previously. The results, obtained by cell
electrofusion, are comparable to usually used polyethylene glycol mediated fusion on the same type of cells.
© 2008 Elsevier B.V. All rights reserved.
1. Introduction
The ability to fuse two different types of cells allows for creation of
a third type of cells that are polynuclear and display hybrid
characteristics of the two original types of cells. Cell fusion has been
used for transfer of foreign receptors into the membrane of the living
cell [1,2] and was also demonstrated as an important process in tissue
regeneration in cell transplantation [3–5]. The later offers possibilities
for targeted cell therapy for organ regeneration. In addition, hybrid
cells can be useful especially in biotechnology for production of
monoclonal antibodies [6,7] and in biomedicine for the production of
hybrid cell vaccines for immunotherapy of cancer [8].
Hybridoma technology is the most often used procedure for
producing monoclonal antibodies [12]. The critical step within this
procedure is fusion of myeloma cells with B-lymphocytes to form
hybridoma cells, which grow in culture and produce these important
biological molecules. Myeloma cells are “fusion partner” cells that
growin culture and lymphocytes are the cells that produce antibodies.
After fusion,cells are plated in HATselection media to obtain onlycells
that are constituted from both types of cells. In some cases, where
mouse or hen cells are used, fusion with polyethylene glycol [9] and
electrofusion give good results [10,11], however the use of human
lymphocytes is favored. The use of human lymphocytes would give us
human monoclonal antibodies, which are more valuable than mouse
monoclonal antibodies for use in human therapy.
Also promising are hybrid cells made of dendritic cells and
autologus tumor cells. These hybrid cells could be used as a vaccine
in cancer immunotherapy. Dendritic cells are most powerful antigen
presenting cells that activate naive T lymphocytes to generate
cytotoxic effectors (cytotoxic T lymphocytes). Hybrid autologus
tumor–dendritic cells would thus express speciﬁc tumor antigens
and be able to activate T cell mediated responses [8]. Due to low
efﬁciency of fusion by means of polyethylene glycol, it is however not
possible to produce hybrid cells in sufﬁcient quantities for the therapy
with this method. Hybrid cells must therefore be further grown in the
culture, thus it is difﬁcult to obtain sufﬁcient number of cells for
therapy in adequately short time.
Fusion of human cells is however most often unsuccessful. The
compromise for hybridoma technology is fusing human cells or
humanB-lymphocyteswithmouseorhenmyelomacells, respectively.
The efﬁciency of such fusion with polyethylene glycol is however not
good enough for efﬁcient production of monoclonal antibodies. The
alternative procedure for obtaining human monoclonal antibodies or
hybrids of dendritic and autologus tumor cells, that can be more
efﬁcient than polyethylene glycol, is cell electrofusion. For cancer
immunotherapy, investigators suggested that electrofusion is an
effective method [13]; justiﬁed to be used in clinical trials besides
previously used fusion by means of polyethylene glycol [14].F o r
production of human monoclonal antibodies from hybrids made of
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lines, no such comparative study of both fusion techniques (poly-
ethylene glycol and electrofusion) has been done before.
Cell electrofusion is a simple and safe method that does not
introduce anysubstances in the cell suspensionso it can be safely used
in all clinical applications, which is clearlyan advantage over chemical
or viral methods. Furthermore, electrofusion effectiveness can be
further improved by optimizing electrical parameters that affect its
efﬁciency. Cells fuse only when they are brought into their fusogenic
state. This fusogenic state seems to correlate well with the
permeabilized state of the membrane [15]. To achieve cell fusion we
must have cells with permeabilized membranes in close contact.
Therefore, in ordertoachieve the highest fusionyield, we must choose
values of electrical parameters, which cause membrane permeabiliza-
tion and good survival of fusion partner cells.
The most important and known electrical parameters governing
membrane electropermeabilization are pulse amplitude, which
enlarges permeabilized area and pulse duration and number of pulses,
which enlarge the density of membrane defects [16]. Another way of
enlarging the permeabilized area without reducing the survival of the
cells that has not been studied until lately is changing electric pulse
direction [17]; i.e. delivering electrical pulses in different directions to
the cells. From the theory of electroporation [18,19] and already
performed experiments [20,21] it follows that applying pulses to cells
in different directions causes permeabilization of different areas of the
cell membrane. Application of pulses in different directions thus
increases the total permeabilized area of the membrane.
It was demonstrated that a prerequisite for cell fusion is that
membranesofbothcellfusionpartnersincontactareintheirfusogenic
state [22]. Contact between cells afterexposing them to electric pulses
in electrofusion is most often established by centrifugation of cells in
suspension. Since in centrifugation contacts between cells create
randomly between already electroporated cells, increased permeabi-
lized area should increase the probability of creating adequate contact
between membranes in fusogenic state of two neighboring cells.
In our study, we therefore ﬁrst investigated the inﬂuence of the
electric ﬁeld direction on electropermeabilization and subsequent
electrofusion in two cell lines (B16F1 and CHOK1, respectively). In the
second part of our study, electrofusion was used for the ﬁrst time for
production of human–mouse heterohybridoma cells with modiﬁed
Koehler and Milstein hybridoma technology [12] and compared to the
most often used polyethylene glycol mediated cell fusion.
2. Materials and methods
2.1. Cells
In the ﬁrst part of our work, we used two adherent cell lines.
Chinese hamster ovary cells (CHOK1) were grown in HAM medium
with added 10% Fetal Calf Serum (both from Sigma, USA). Mouse
melanoma cells (B16F1) were grown in Eagle's Minimum Essential
Medium (EMEM) with added 10% Fetal Calf Serum (both from Sigma,
USA). After trypsinization, cells were centrifuged for 5 min at
1000 rpm at 4 °C and resuspended in isoosmolar low conductance
(pulsing medium) to obtain 5×10
6 cells/ml. This medium with pH 7.4
consists of 250 mM sucrose, 10 mM phosphate (K2HPO4/KH2PO4) and
1 mM MgCl2 as was previously described elsewhere [23].
For productionofheterohybridomaintheﬁnalpartofourstudy,we
used human spleen lymphoblasts and NS1—mouse myeloma cells—as
fusion partners. Lymphoblasts were isolated and frozen in liquid
nitrogen.Oneweekbeforetheexperiment,theywerethawedandkept
in DMEM medium with added 13% Fetal Calf Serum (both from Sigma,
USA). HAT-sensitive NS1 myeloma cells were also cultured in DMEM
medium with added 13% Fetal Calf Serum. The myeloma cells were
used for fusion when they were in exponential growth phase.
2.2. Electropermeabilization
A 100 µl droplet of cells suspended in the pulsing medium
(≈5×10
5 cells) was taken and placed between four cylinder stainless
steel electrodes [17] of diameter 2 mm, which were positioned in
corners of a quadrant with a distance between the opposite electrodes
d=5 mm. The entrapped droplet wetted all four electrodes and thus
formed electric contact between all four of them (Fig. 1a).
Cells were exposed to three different combinations of 6 or 10
pulses with the amplitude of 400 or 500 V. In all experiments, pulses
were 100 µs long and their repetition frequency was 77 Hz. Each
combination of the pulses was further used in three different pulsing
sequences (Fig.1b) which resulted in different electric ﬁeld directions
of the pulses (same direction, opposite directions and two directions
perpendicular to each other).
After exposure of cells to electric pulses, cell suspension was
transferred by micropipette from the place between the electrodes to
the 24-microtiterplate holes. Propidium iodide (Sigma,USA) was used
to determine the degree of permeabilization of cells [24]. This
nonpermeant ﬂuorescent dye was added to the cell suspension before
electroporation in quantity that gave 0.01 mM concentration of
propidium iodide in the cell suspension.
Propidium iodide enters the cells when they are permeabilized as
described earlier [24] and binds on cell's DNA. When bound, its
ﬂuorescence increases 1000 times. Propidium iodide is toxic and
eventually enters in nonpermeabilized cells as well so all the
measurements must be ﬁnished in less than 30 min after the addition
of the dye.
Permeabilizationwas determined as the ratio between the number
of ﬂuorescent cells and the total number of cells in the ﬁeld of view.
We observed cells under the inverted ﬂuorescent microscope Axiovert
200 (Zeiss, Germany). Phase contrast and ﬂuorescence images of the
same areas were taken between 5 and 9 min after the electroporation
with digital IMAGO CCD camera VISICAM 1280 (Visitron, Germany)
with the resolution 1280×1024 pixels and were analyzed with Meta
Morph 5.0 (Visitron, Germany). Excitation was set at 510 nm
Fig.1. a) Schematic of electrodes and the drop of cell suspension between them. b) Directions of pulsing sequences: pulses in same directions (⇨), pulses in opposite directions (⬄ )
and pulses in two directions perpendicular to each other (⇨⇩ ). c) At treatments with pulses in perpendicular directions, pulses were applied between opposite electrodes. Resulting
electric ﬁeld is depicted with dashed arrows (for pulses applied between electrodes 1 and 3) and solid arrows (for pulses applied between electrodes 2 and 4).
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(Rhodamin ﬁlter BP 580/30).
2.3. Electrofusion
For electrofusion, we used the protocol where contact between
cells was established by means of centrifugation as previously
described [25,26]. After exposing cells to electric ﬁeld (see Section
2.2), cell suspension was transferred by micropipette to a centrifuge
tube and in a centrifuge in less than 20 s after the electroporation. The
electroporated cells were centrifuged 5 min at 525 rpm at 4 °C. Next
10 min cells in centrifuge tubes were incubated at 37 °C and 5% CO2.
After this procedure, cells were placed in Petri dishes and incubated at
37 °C and 5% CO2 for 24 h.
We observed adhered cells with inverted optical microscope CK40
(Olympus, Japan). Images were taken from live cells in the medium or
from cells ﬁxed ﬁrst with absolute methanol and dyed with Giemsa
dye. For each experiment, we counted at least 400 cells. All
experiments were repeated three times.
Fusion yield FY was calculated as a number of nuclei in multi-
nucleated cells divided by number of all nuclei.
FY ¼
number of nuclei in multinucleated cells
number of all nuclei
ð1Þ
FY values can be from zero to one. Zero means there are no
polynucleated cells, at one all cells would be polynucleated. In the
next step, we considered the survival of the cells (S) in each treatment.
We deﬁned number of nuclei in control treatment (no electric pulses)
as 100% (all cells survive). We determined the survival S in different
treatments according to this number. Actual fusionyield FY⁎ was then
calculated considered cell survival, thus correcting FY.
FY4 ¼ FYd S k ½  ð 2Þ
FY⁎ values can be from zero to one, because FY is between zero and
one and survival S is between zero and hundred percent, but FY⁎ is
always smaller than FY since S is smaller than 100%. Furthermore, in
practical use of fused cells, we areusually not interested in their nuclei
number but in the yield of functional fused cells. Namely some fused
cells can contain large (N2) number of nuclei, which reduces the
number of cells obtained. On the picture 2a, B16F1 cell with three
nuclei can be seen and on the picture 2b, two CHOK1 cells with two
nuclei can be seen.
We thus considered the average number of nuclei in the
polynucleated cells for different treatments, so called index of
Fig. 2. Phase contrast pictures with 20× magniﬁcation a) B16F1 cells, cell marked with
an arrow has three nuclei. b) CHOK1 cells: cells, marked with arrows have two nuclei.
Fig. 3. Permeabilization of a) B16F1 and b) CHOK1 cells. Cells were pulsed in suspension.
The length of square-wave pulses was 100 μs and repetition frequency of pulses was
77 Hz. Numbers of pulses applied were 6 and 10. The pulse amplitudes were 400 V and
500 V. Three different combinations of pulse directions were used: pulses applied in
same directions (⇨), pulses applied in opposite directions (⬄) and pulses applied in two
directions perpendicular to each other (⇨⇩ ). Values are given as a mean±SD.
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as
FY44 ¼ FY4d 2=IP ð3Þ
Ip in ideal situation of the fusion would be two, meaning that each
cell fused with one another cell resulting in all polynucleated cells
having two nuclei. If the number of nuclei is higher than two, FY⁎⁎ is
smallerthan FY⁎.F Y ⁎⁎ is thus the most conservativeestimate of fusion
yield taking into account also survival and index of polynucleation
(Fig. 2).
2.4. Hybridoma technology
For production of heterohybridoma, we used human spleen
lymphoblasts and mouse myeloma NS1 cells. We mixed both cells in
the ratio of 1:1 in the pulsingmedium at the sameconcentration as for
CHOK1 or B16F1 cells (5×10
6 cells/ml) and then fused them by using
the same protocol as for CHOK1 or B16F1 cells.
After exposing cells to the electric ﬁeld, as we described in Section
2.2, the cell suspension was transferred by micropipette to a
centrifuge tube and into a centrifuge in less than 20 s after the
electroporation. The electroporated cells were centrifuged for 5 min at
525 rpm at 4 °C. Next 10 min cells in centrifuge tubes were incubated
at 37 °C and 5% CO2.
After the electrofusion procedure, cells were resuspended in
DMEM medium with 13% FCS and transferred in units of 5×10
4 cells
to the 96-well culture plates.
After 24 h, HATselection mediumwas added and replaced with HT
mediumaftertwoweeks.About3 weeks laterheterohybridomaswere
counted under inverted microscope and transferred into conventional
24-well culture plates for growing.
Results (permeabilization and fusion yield) are given in a form of
multiple bar graphs (SigmaPlot 9.0, Systat, USA) where every point
represents the mean of three independent experiments and the error
bars indicate the standard deviation(Figs. 3 and 4). Statistical test, One
way analysis of variance (One way ANOVA), was performed on all
results (SigmaStat 3.1, Systat, USA). Bonferroni t-test was performed
on results if therewas indication of a statistically signiﬁcant difference
between different electric ﬁeld protocols used.
3. Results
3.1. Electropermeabilization
The permeabilization of cell membrane and the percentage of
permeabilized cells in suspension are increased with an increase in
the pulse amplitude and with the number of pulses as expected and
described before, and can be seen in Fig. 3a and b ( pulses delivered in
the same directions). The effect of electric ﬁeld direction is however
more interesting because its role in cell electrofusion has not been
extensively studied yet.
Pulsing cells in two opposite directions caused almost no
difference in permeabilization in comparison to pulsing cells in one
direction while permeabilization is increased for the same pulse
amplitude and number of pulses by using pulses in two perpendicular
directions (pb0.001). The effects of the observed parameters were
similar for both cell lines under investigation, the B16F1 and CHOK1
cells (Fig. 3a and b).
3.2. Electrofusion
The fusionyield FY was generally increased with an increase in the
pulse amplitude and in the number of pulses (Fig. 4) although number
of pulses and pulse amplitudes were chosen close together so that the
Fig. 4. Fusionyield of a) B16F1 and b) CHOK1 cells. Note: FY⁎⁎ is given for B16F1 and FY⁎
is given for CHOK1. Cells were pulsed in suspension. The length of square-wave pulses
was 100 μs and frequency of pulses was 77 Hz in all experiments. Numbers of pulses
applied were 6 and 10. The pulse amplitudes were 400 V and 500 V. Three different
combinations of pulse directions were used: pulses applied in same directions (⇨),
pulses applied in opposite directions (⬄) and pulses applied in two directions
perpendicular to each other (⇨⇩ ). Fusion yield presented is corrected for survival and
polynucleation of cells in each treatment for B16F1 cells and for survival only for CHOK1
cells. Values are given as a mean±SD.
Table 1
Survival of B16F1 and CHOK1 cells in the experiments of cell fusion
Survival of cells [%] 6 pulses,
100 μs, 400 V
10 pulses,
100 μs, 400 V
10 pulses,
100 μs, 500 V
B16F1 ⇨ 101.8±0.02 103.6±0.05 104.1±0.1
⬄ 95.0±0.1 103.5±0.2 96.7±0.1
⇨⇩ 91.9±0.1 92.1±0.1 86.9±0.1
CHOK1 ⇨ 90.2±0.1 98.8±0.3 87.9±0.1
⬄ 85.1±0.2 86.5±0.2 84.1±0.2
⇨⇩ 82.6±0.1 80.3±0.1 77.2±0.2
Values are given as a mean±SD.
Table 2
Polynucleation index for fusion of B16F1 and CHOK1 cells
Polynucleation
index [IP]
6 pulses,
100 μs, 400 V
10 pulses,
100 μs, 400 V
10 pulses,
100 μs, 500 V
B16F1 ⇨ 2.3±0.2 2.2±0.2 2.2±0.1
⬄ 2.3±0.2 2.2±0.2 2.2±0.1
⇨⇩ 2.2±0.1 2.3±0.1 2.2±0.1
CHOK1 ⇨ 2.1±0.05 2.1±0.1 2.1±0.05
⬄ 2.1±0.1 2.0±0.1 2.1±0.02
⇨⇩ 2.4±0.2 2.2±0.2 2.3±0.2
Values are given as a mean±SD.
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delivered), we observed polynucleated cells that are always present in
the cell culture. For CHO cells there was approximately 17% and for
B16F1 cells 19% of inherently polynucleated cells.
The fusion yields shown are multiplied with the cell survival
(Table 1) according to Eq. (2) in order to take into account also the cell
survival. Survival of CHOK1 cells was consistently lower than the
survival of B16F1 cells for about 10%.
For each pulse combination, we also evaluated index of poly-
nucleation—i.e.the averagenumberofnuclei in onepolynucleated cell
(Table 2). The level of polynucleation was between 2.0 and 2.4; it was
the same in both cell lines and did not depend on different protocols
used. When we took into account the level of polynucleation (Eq. (3)),
most of the signiﬁcant differences between treatments for CHOK1
cells were no longer present. The differences in fusion yield between
treatments with different number of pulses remained noticeable also
when we took into account the level of polynucleation.
3.3. Hybridoma technology
In our present work, we also used electrofusion to produce
human–mouse heterohybridoma cells from human lymphocytes and
mouse myeloma cell line NS1 with modiﬁed Koehler and Milstein
hybridoma technology. We were able to obtain viable human–mouse
heterohybridoma in amounts that are comparable to those obtained
by fusing the same cells by means of polyethylene glycol (data not
published).
We used the treatment procedures that worked best on B16F1 and
CHOK1 cells (pulses in two directions perpendicular to each other)
and also treatments with prolonged pulses (Table 3). Our results show
that treatments with pulse amplitudes of 400 V are suboptimal for
making lymphocytes fusogene and treatments with ten pulses 500 μs
long were probably too strong for myeloma cells to survive.
4. Discussion
In our present study, we examined the effect of different electric
pulse parameters on electropermeabilization and electrofusion in two
celllines.Wewereespeciallyinterestedintheeffectthatthedirectionof
theelectricﬁeldmighthaveoncellfusion.Eventhoughweintentionally
worked at suboptimal conditions in order to be able to detect expected
differences with changing the direction of electric ﬁeld, fusion yield
obtained in our study was comparable to the fusion yield obtained by
means of electrofusion by other researchers [27–29].A to p t i m a lv a l u e s
ofstudiedparameters,thevaluesoffusionyields,afterthesubtractionof
the polynucleated cells in control samples, are approaching 20%.
The effect of the electric ﬁeld direction on fusion yield is similar as
for permeabilization of cells. We did not observe the difference
between pulsing cells in one direction and pulsing cells in two
opposite directions. Fusion yield is however increased when pulsing
cells in two perpendicular directions for the same pulse amplitude
and number of pulses.
We observed consistently lower survival of CHOK1 cells than of
B16F1 cells for about 10%. Since B16F1 cells are somewhat larger than
CHOK1 cells, the difference in the survival is not due to the cell size
effect on the sensitivity of the cells to the electric ﬁeld. It was shown
thatB16F1cells arelesssensitivetoelectric ﬁelddue totheirbiological
properties [30]. The other reason is probablyalso the larger sensitivity
of CHOK1 cells to mechanical and other manipulation.
The level of polynucleation was between 2.0 and 2.4 and did not
depend on different protocols used. The level of polynucleation is
however important, because obtaining cells with huge number of
nuclei reduces the number of polynucleated cells and additionally
large cells are less likely to survive and divide. The ideal level of
polynucleation values therefore should not be much higher than 2.
The observed effects due to different parameters used, were
similar for both investigated cell lines although the differences were
more pronounced for the B16F1 cell line (Fig. 4). For CHOK1 cells we
have shown only the FY⁎, because at the FY⁎⁎ level signiﬁcant
differences between different treatments were not apparent, while for
the B16F1 cells the differences remained visible also when we further
took into account the level of polynucleation.
The degree of permeabilization and fusion yield was higher at
treatments with higher pulse amplitude and larger number of pulses.
This effectof pulseamplitude andnumberis in agreementwithTeissie
and Ramos, 98 [15]. In their study, they observed a strong correlation
between permeabilization and fusion.
In our study, we focused on observing differences between the
treatments delivering pulses in different directions. We obtained the
highest fusion yield when delivering pulses in two directions
perpendicular to each other, while the effect of using pulses in two
opposite directions was not signiﬁcantly different when compared to
delivering pulses in the same direction. That was expected and it is in
agreement with the theory of electroporation [17,18] and experiments
done by others [20,31].
The differences between differentelectric protocols used, however,
are not large. The reason for that in our opinion is in the design of the
electrodes. Only part of the cells in suspension drop was actually
exposed tothe pulses in claimed directions. This effect is most obvious
whenpulses areapplied in twodirections perpendicular toeach other.
Large outer part of the cell suspension is actually exposed only to the
ﬁeld in the same or in two opposite directions (Fig. 1c). The design of
the electrodes has since been improved in order to resolve this
problem [32].
In our study, we also noticed that survival for treatments, where
the electric ﬁeld direction was changed, was lower than in the
treatments where pulses were applied in only one direction. The
reason for that is probably in the fact that in the case of changing
electric ﬁeld more cells is in close proximity to an energized electrode
and therefore a high electric ﬁeld. In our design of new electrodes, we
have predicted the possibility of covering the surface of the electrodes
with the ﬁller material, which would conduct the electric current in
the same range as our medium and on the other hand, it would
function as a mechanical barrier between the cells and the electrode
surface. This barrier would exclude cells from the proximity of the
electrode surface and thus reduce the number of cells being killed
while applying electric ﬁeld. As it was suggested already by Schmeer
[33].
The advantage of our method of detection of fused cells by
counting nuclei after 20 to 24 h is that we count only the cells that
actually survived. This is important, because only cells that actually
survive and divide are useful in obtaining hybrid cells for monoclonal
antibodies or hybrid autologus tumor–dendritic cells production. On
the other hand, this method has a drawback that nuclei in fused cells
can also fuse [34]. Therefore, in estimation of fusion yield we
depended also on cell and nuclei sizes, which are not linearly
dependent on nuclei number in the cell and therefore cannot be
relied on completely.
In the second part of our study, we used electrofusion technique in
hybridoma technology for fusion of smallerhuman lymphoblasts with
Table 3
Results of fusion of human lymphoblasts and myeloma cells
Pulse
amplitude
[V]
Number of
pulses
Length of
pulses [ μs]
Wells
seeded
Wells where
clones appeared
Viable
hybridoma
400 6 100 27 / /
400 10 100 27 / /
500 10 100 70 21 [30%] 5
500 10 200 18 6 [33%] 1
500 10 500 27 2 [7%] /
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heterohybridomas is never as good as the yield of mouse–mouse or
human–human hybridomas due to the chromosome loss [12].W e
succeeded in producing heterohybridomas in the amounts that are
comparable to those previously obtained by the means of polyethy-
lene glycol.
Furthermore, we used electrical conditions that were the most
successful in the ﬁrst part of our study. This can be useful for
comparing the results but was not necessarily optimal for fusion of
human lymphoblasts with NS1 cells. Lymphoblasts are namely
approximately twice smaller in diameter than NS1 cells and are
therefore less prone to electropermeabilization under the same
conditions than larger NS1 cells. For permeabilization of lympho-
blasts, we would need higher pulse amplitude or number of pulses
than for permeabilization of myeloma NS1 cells [35]. On the other
hand, it was shown in the case of primary and transformed human
amnion cells that primarycells are more sensitive to electric ﬁeld than
transformed cells [36]. Since lymphoblasts are primary cells, they
could be more sensitive to electric ﬁeld even though they are of
smaller size.
In our experiments, we observed that after exposure to electric
pulses myeloma cells were in bad shape. That makes us believe that
they were seriously damaged by exposure to electric pulses. At the
same time, treatments with longer pulses, higher pulse amplitude or
more pulses were needed for obtaining hybridoma (Table 3). This
supports our conclusion that lymphoblasts were fusogenic only after
treatments with longer pulses, larger pulse amplitude or more pulses.
We expect that pulses with even larger amplitude could be more
successful due to enlarged area of permeabilized membrane [37] but
current electrode design and pulse generator limitations did not allow
us to use them. If we could use larger amplitudes, we would most
probably encounter a problem of viability of the NS1 cells, which were
permeabilized at the same time with the lymphoblasts. Therefore, we
suggest raise of myeloma cells fraction from half as used in our study
to 90% or separate permeabilization of different types of cells and
consequent fusion in order to achieve optimal fusogenicity and
survival of both fusion partner cells.
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